Professor R. Keith Campbell, MBA, BPharm, CDE, now retired from Washington State University College of Pharmacy, highlights the clinical advantages of Afrezza based on the evidence as well as his personal perspective.
R. Keith Campbell, MBA, BPharm, CDE
Advertisement
Articles by R. Keith Campbell, MBA, BPharm, CDE
Advertisement
Latest Updated Articles
- Afrezza: Treating Diabetes in a Physiologic Manner
September 16th 2016
Advertisement
Advertisement
Trending on AJMC
1
Bepirovirsen Approval Offers New Option for Chronic HBV Treatment
2
Inhaled Amikacin Raises Culture Conversion in New MAC Lung Disease
3
Uninsured Rate Rises to 11.2% as Coverage Erodes Before Medicaid Cuts
4
Bronchiectasis GWAS Highlights Candidate Targets Shared With COPD
5